|                                                                           

NB Diagnostics has developed a range of biochemical assays for assessment of bone and cartilage disease.
These assays can be utilized as a tool in monitoring therapy and as an early prediction of the long-term skeletal
response to these therapies. Furthermore, the assays can shorten the time of pre-clinical and clinical studies
and thus represent significant value for the pharmaceutical and biotechnology industry.

 

  Serum CrossLaps ELISA

 Bone Resorption Marker(CTX-I) For Clinical Trial & Patient Monitoring 
                       
   Catalogue     Product Insert   reference

  N-MID Osteocalcin ELISA  Bone Formation Marker For Clinical Trials & Patient Monitoring
                         
Catalogue     Product Insert    reference
  RatLaps ELISA  Bone Resorption Marker(CTX-I) For Monitoring Preclinical Trials
                         
Catalogue     Product Insert    reference
  Rat-MID Osteocalcin ELISA

 Bone Formation Marker For Monitoring Preclinical Trials
                         
Catalogue     Product Insert    reference

  CrossLaps for Culture ELISA

 Bone Resorption Marker(CTX-I) For Preclinical Research
                         
Catalogue     Product Insert    reference

  Urine CartiLaps ELISA

 Cartilage Degradation Marker(CTX-II) For Clinical Research
                         
Catalogue     Product Insert    reference

  Pre-Clinical CartiLaps ELISA

 Cartilage Degradation Marker(CTX-II) For Preclinical Research
                         
Catalogue     Product Insert    reference

  ALPHA CrossLaps ELISA

 High-Turnover Bone Resorption Marker For Clinical Trials & Patient Monitoring
                         
Catalogue     Product Insert    reference